dc.contributor.author | Mbodj, Mamadou | |
dc.contributor.author | Mundinger, Alexander | |
dc.contributor.author | Orda, Ruben | |
dc.contributor.author | Ostapenko, Valerijus | |
dc.contributor.author | Ozbas, Serdar | |
dc.contributor.author | Ozmen, Vahit | |
dc.contributor.author | Pagani, Olivia | |
dc.contributor.author | Pienkowski, Tadeusz | |
dc.contributor.author | Schneebaum, Schlomo | |
dc.contributor.author | Shmalts, Ekaterina | |
dc.contributor.author | Selim, Ashraf | |
dc.contributor.author | Pavel, Zotov | |
dc.contributor.author | Lodi, Massimo | |
dc.contributor.author | Maghales-Costa, Mauricio | |
dc.contributor.author | Mathelin, Carole | |
dc.contributor.author | Ame, Shanti | |
dc.contributor.author | Anyanwu, Stanley | |
dc.contributor.author | Avisar, Eli | |
dc.contributor.author | Boubnider, Wahib Mohcen | |
dc.contributor.author | Breitling, Katrin | |
dc.contributor.author | Anie, Hannah Ayettey | |
dc.contributor.author | Conceicao, Jose Carlos | |
dc.contributor.author | Dupont, Veronique | |
dc.contributor.author | Elder, Elisabeth | |
dc.contributor.author | Elfgen, Constanze | |
dc.contributor.author | Elonge, Tony | |
dc.contributor.author | Iglesias, Edelmiro | |
dc.contributor.author | Imoto, Shigeru | |
dc.contributor.author | Ioannidou-Mouzaka, Lydia | |
dc.contributor.author | Kappos, Elisabeth A. | |
dc.contributor.author | Kaufmann, Martin | |
dc.contributor.author | Knauer, Michael | |
dc.contributor.author | Luzuy, Franck | |
dc.contributor.author | Margaritoni, Marko | |
dc.date.accessioned | 2021-12-10T12:21:20Z | |
dc.date.available | 2021-12-10T12:21:20Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Mathelin C., Ame S., Anyanwu S., Avisar E., Boubnider W. M. , Breitling K., Anie H. A. , Conceicao J. C. , Dupont V., Elder E., et al., "Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey", EUROPEAN JOURNAL OF BREAST HEALTH, cilt.17, sa.2, ss.188-196, 2021 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b707b638-bdde-4a63-8003-dce5fd55b9d6 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/173710 | |
dc.identifier.uri | https://avesis.istanbul.edu.tr/api/publication/b707b638-bdde-4a63-8003-dce5fd55b9d6/file | |
dc.identifier.uri | https://doi.org/10.4274/ejbh.galenos.2021.2021-1-4 | |
dc.description.abstract | Objective: In early 2020, the spread of coronavirus disease-2019 (COVID-19) led the World Health Organization to declare this disease a pandemic. Initial epidemiological data showed that patients with cancer were at high risk of developing severe forms of COVID-19. National scientific societies published recommendations modifying the patients' breast cancer (BC) management to preserve, in theory, quality oncologic care, avoiding the increased risk of contamination. The Senology International Society (SIS) decided to take an inventory of the actions taken worldwide. This study investigates COVID-19-related changes concerning BC management and analyzes the will to maintain them after the pandemic, evaluating their oncological safety consequences. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Health Sciences | |
dc.subject | Oncology | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey | |
dc.type | Makale | |
dc.relation.journal | EUROPEAN JOURNAL OF BREAST HEALTH | |
dc.contributor.department | Inst Cancerol Strasbourg Europe ICANS , , | |
dc.identifier.volume | 17 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 188 | |
dc.identifier.endpage | 196 | |
dc.contributor.firstauthorID | 2718238 | |